EVP R&D, Chief Medical Officer
Thu, Jan 30, 2025
Jan 30
100,918 shares @ $32.05
Decreased holdings by -69.50%
4th largest trade (out of 157)
Planned (10b5-1)Large Trade
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 18% above 200-day moving average